KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Shares Issued (2016 - 2025)

Ionis Pharmaceuticals has reported Shares Issued over the past 17 years, most recently at -$84.8 million for Q4 2025.

  • Quarterly results put Shares Issued at -$84.8 million for Q4 2025, down 21191.29% from a year ago — trailing twelve months through Sep 2025 was $85.2 million (down 83.47% YoY), and the annual figure for FY2024 was $33.6 million, changed.
  • Shares Issued for Q4 2025 was -$84.8 million at Ionis Pharmaceuticals, down from $81.3 million in the prior quarter.
  • Over the last five years, Shares Issued for IONS hit a ceiling of $489.1 million in Q3 2024 and a floor of -$84.8 million in Q4 2025.
  • Median Shares Issued over the past 5 years was $2.0 million (2022), compared with a mean of $25.1 million.
  • Biggest five-year swings in Shares Issued: skyrocketed 9980.81% in 2024 and later plummeted 21191.29% in 2025.
  • Ionis Pharmaceuticals' Shares Issued stood at -$78.2 million in 2021, then surged by 100.44% to $343000.0 in 2022, then plummeted by 1543.15% to -$5.0 million in 2023, then surged by 108.12% to $402000.0 in 2024, then plummeted by 21191.29% to -$84.8 million in 2025.
  • The last three reported values for Shares Issued were -$84.8 million (Q4 2025), $81.3 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.